Concepedia

Author

Ken Sato

Gunma UniversityORCID

Also Known As

Hitoshi Takagi, Ichiro Kusumi, K I Sato, K SATO, K Sato, K. Sato, K.-I. Sato, K.-i Sato, K.-i. Sato, KEN SATO

528

Publications

6.4K

Citations

43

H-Index

246

Concepts

All Affiliations

Gunma UniversityGunma University HospitalNational Hospital OrganizationOkayama Medical CenterNational Hospital Organization Takasaki Medical Center
KS

About

Ken Sato is an author at Gunma University specializing in medicine, hepatology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

24

60

2K

2

Health Sciences

14

18

567

3

Engineering

13

17

662

4

Language Studies

6

6

430

5

Natural Sciences

3

3

82

Ken Sato

×

139

Publications

5.3K

Citations

41

H-Index

YearCitations

Evidence-based clinical practice guidelines for irritable bowel syndrome

Shin Fukudo, Hiroshi Kaneko, Hirotada Akiho,

Journal of Gastroenterology

2014

218

Evidence-based clinical practice guidelines for irritable bowel syndrome 2020

Shin Fukudo, Toshikatsu Okumura, Masahiko Inamori,

Journal of Gastroenterology

2021

172

Randomized phase 3 trial of ombitasvir/paritaprevir/ritonavir for hepatitis C virus genotype 1b–infected Japanese patients with or without cirrhosis

Hiromitsu Kumada, Kazuaki Chayama, Lino Rodrigues,

Hepatology

2015

153

Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Clinical Characteristics, Prognosis, and Patient Survival Analysis

Daichi Takizawa, Satoru Kakizaki, Naondo Sohara,

Digestive Diseases and Sciences

2007

144

A Prospective Randomized Controlled Study of Long-Term Combination Therapy Using Ursodeoxycholic Acid and Bezafibrate in Patients With Primary Biliary Cirrhosis and Dyslipidemia

Kenichi Hosonuma, Ken Sato, Yuichi Yamazaki,

The American Journal of Gastroenterology

2015

115

Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection

Hiromitsu Kumada, Tsunamasa Watanabe, Fumitaka Suzuki,

Journal of Gastroenterology

2017

115

Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis

Kazuaki Chayama, Fumitaka Suzuki, Yoshiyasu Karino,

Journal of Gastroenterology

2017

114

Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection

Hidenori Toyoda, Kazuaki Chayama, Fumitaka Suzuki,

Hepatology

2017

112

Bezafibrate Improves GLOBE and UK‐PBC Scores and Long‐Term Outcomes in Patients With Primary Biliary Cholangitis

Akira Honda, Atsushi Tanaka, Tetsuji Kaneko,

Hepatology

2019

111

Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C

Hitoshi Takagi, Takahiko Nagamine, Takehiko Abe,

Journal of Viral Hepatitis

2001

100

Page 1